Evaluation of a nurse-led program for the prevention of complications of long-term glucocorticoids (COCORTICO): study protocol for a randomized trial.
Solen Nicol, Kilian Trin, Lori-Anne Simon...
https://pubmed.ncbi.nlm.nih.gov/41250159/Actively Recruiting
Led by University Hospital, Brest · Updated on 2026-03-20
191
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are evaluating the long-term benefits of a nurse-led prevention program for adults starting extended corticosteroid therapy. This therapy is commonly used in various medical conditions but can cause serious side effects including bone, metabolic, and infectious complications. The study aims to compare this nurse-led program to routine care in reducing these adverse events and improving quality of life over one year. Participants are randomly assigned to one of two groups one group receives standard care plus a general summary sheet of preventive measures without individual assessment the other group participates in a nurse-led prevention program that includes an educational video, personal nurse interviews, dietitian consultations, tailored preventive advice sheets for patients and their doctors, and follow-up phone calls at 12, 24, and 36 weeks. Both groups are monitored for 52 weeks. Throughout the study, participants will attend baseline and week-52 visits involving clinical evaluations, routine lab tests, bone density scans, and quality of life questionnaires. Corticosteroid use is tracked continuously via a dedicated notebook. An independent physician blinded to group assignment assesses the overall burden of corticosteroid-related adverse events at the end of the study using the glucocorticoid toxicity index. The study will also monitor the occurrence of specific complications, adherence to preventive measures, and cumulative steroid dosage.
CONDITIONS
Evaluation of a Nurse-led Program for the Prevention of Complications of Long-term Corticosteroid Therapy
S
Solen NICOL
D
Dewi GELLEC, PH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Brest
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for baseline evaluation and consent
Duration - 52 weeks
Participants receive either a nurse-led prevention program with educational sessions and scheduled follow-up calls, or standard care with a general summary sheet of preventive measures provided by their physician.
1 baseline visit, plus phone calls at week 12, week 24, and week 36 for those in the nurse-led program; 1 follow-up visit at week 52 for all participants
Duration - At week 52
Participants complete the final evaluation to assess the burden of corticosteroid-related adverse events and quality of life.
1 follow-up visit (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Solen Nicol, Kilian Trin, Lori-Anne Simon...
https://pubmed.ncbi.nlm.nih.gov/41250159/University Hospital, Brest
Lead Sponsor